How to Cite
Abstract
Nowadays, the benefit of use aspirin in low doses for the prevention of preeclampsia is well established in high-risk women, while use in low risk women is still questioned by what most experts do not recommend. There are still questions to be answered regarding the specific aspects of the therapy, however, aspirin in low doses is a safe medication during pregnancy and is also widely available in our country, it is recommended to use in a prophylaxis in women identified as high risk according to the USPSTF criteria, in order to obtain a modest reduction (greater than 10%) in the risk of developing preeclampsia (Grade 2B). The prevention of associated sequelae such as preterm delivery and IUGR is also possible, although additional studies are needed to corroborate these results.
Keywords
References
2. August, P.. (June 2017). Preeclampsia: Prevention. UpToDate, vol, pp.1-23. July 2017, De UpToDate Base de datos.
3. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ Task Force on Hyper- tension in Pregnancy. Obstet Gynecol 2013; 122:1122-31.
4. Rolnik,Wright,Liona,O’Gorman & Syngelaki, A.. (June 28, 2017). Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. The new england journal of medicine, DOI:10.1056/NEJMoa1704559, pp1-10.
5. American College of Obstetricians and Gynecologists. Practice advisory on low-dose aspirin and prevention of preeclampsia: Updated recommendations. http://www.acog.org/AboutACOG/News- Room/Practice-Advisories/Practice-Advisory-Low-Dose-Aspirin-and-Preventionof-Preeclampsia- Updated- Recommendations (Accessed on July 3, 2017).